Nicotine-Free E-Cigarettes Might Promote Tobacco Smoking Reduction Better Than Nicotine Delivery Devices: Results of a Double-Blind Randomized Controlled Trial at 1 Year.


Journal

Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503

Informations de publication

Date de publication:
11 11 2022
Historique:
received: 15 09 2022
revised: 28 10 2022
accepted: 09 11 2022
entrez: 24 11 2022
pubmed: 25 11 2022
medline: 29 11 2022
Statut: epublish

Résumé

The purpose of the present study was to determine whether the use of e-cigarettes to aid in quitting contributed to the increase in the pulmonary health of chronic smokers. The efficacy of e-cigarettes to support a successful smoking cessation attempt was also investigated. A total of 210 smokers (78 women) were enrolled in a screening program for the early detection of lung cancer and distributed in three arms: nicotine e-cigarette plus support, nicotine-free e-cigarette plus support, and support. Results showed that participants in the nicotine e-cigarette arm had a significant and fast decrease in daily cigarettes, but that later they resume smoking more than the other two groups. Conversely, participants in the other two arms showed similar daily consumption at the two evaluation points. Among abstinent participants, only 12.5% reported cough, while 48% of current smokers had pulmonary symptoms. Our study suggests that, in the long run, the use of a nicotine-free liquid may favor reducing smoking and could be considered a good option in a clinical setting.

Identifiants

pubmed: 36421329
pii: curroncol29110676
doi: 10.3390/curroncol29110676
pmc: PMC9717729
doi:

Substances chimiques

Nicotine 6M3C89ZY6R

Types de publication

Randomized Controlled Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8579-8590

Références

Nicotine Tob Res. 2020 Apr 21;22(5):655-662
pubmed: 30768136
Nicotine Tob Res. 2021 Oct 7;23(11):1972-1976
pubmed: 33837422
Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):1945-53
pubmed: 20647410
J Environ Manage. 2019 May 15;238:10-17
pubmed: 30836280
Annu Rev Pharmacol Toxicol. 2022 Jan 6;62:301-322
pubmed: 34555289
PLoS One. 2018 Jul 25;13(7):e0198681
pubmed: 30044773
Health Qual Life Outcomes. 2012 Jan 09;10:4
pubmed: 22230731
Transl Lung Cancer Res. 2018 Jun;7(3):272-280
pubmed: 30050765
JAMA. 2020 Nov 10;324(18):1844-1854
pubmed: 33170240
Am J Prev Med. 2020 Mar;58(3):446-452
pubmed: 31924460
JAMA. 2020 Nov 10;324(18):1835-1837
pubmed: 33170225
Psychol Rep. 2008 Jun;102(3):687-94
pubmed: 18763437
Lancet Respir Med. 2020 Jan;8(1):54-64
pubmed: 31515173
Addict Behav. 2020 Apr;103:106222
pubmed: 31838445
Expert Rev Respir Med. 2019 Sep;13(9):899-915
pubmed: 31375047
PLoS One. 2020 Sep 2;15(9):e0237938
pubmed: 32877429
Transl Lung Cancer Res. 2021 Feb;10(2):1099-1109
pubmed: 33718048
JMIR Res Protoc. 2016 Feb 03;5(1):e21
pubmed: 26842790
Nicotine Tob Res. 2019 Aug 19;21(9):1259-1266
pubmed: 30203076
Exp Clin Psychopharmacol. 2021 Dec;29(6):625-635
pubmed: 32658532
Drug Alcohol Depend. 2019 Jan 1;194:363-370
pubmed: 30472577
Nicotine Tob Res. 2021 Mar 19;23(4):625-634
pubmed: 32939543
Am J Epidemiol. 2018 Nov 1;187(11):2397-2404
pubmed: 29955810
Nicotine Tob Res. 2021 Mar 19;23(4):635-642
pubmed: 32803250
Ann Intern Med. 2012 Dec 4;157(11):776-84
pubmed: 23208167
Lung Cancer. 2021 Mar;153:11-20
pubmed: 33429159
Thorax. 2003 Apr;58(4):339-43
pubmed: 12668799
J Psychosom Res. 2002 Feb;52(2):69-77
pubmed: 11832252
Cancer Prev Res (Phila). 2015 Sep;8(9):873-8
pubmed: 26333731
Cochrane Database Syst Rev. 2020 Oct 14;10:CD010216
pubmed: 33052602
Am J Prev Med. 2020 Feb;58(2):182-190
pubmed: 31859175
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Mayo Clin Proc. 2015 Jan;90(1):128-34
pubmed: 25572196
Am J Physiol Lung Cell Mol Physiol. 2017 Aug 1;313(2):L193-L206
pubmed: 28522559
Support Care Cancer. 1999 May;7(3):121-7
pubmed: 10335929
Nicotine Tob Res. 2019 Jan 1;21(1):119-126
pubmed: 29660034
N Engl J Med. 2019 Feb 14;380(7):629-637
pubmed: 30699054
JAMA Pediatr. 2018 Feb 1;172(2):181-187
pubmed: 29297010
Annu Rev Med. 2016;67:467-86
pubmed: 26332005

Auteurs

Claudio Lucchiari (C)

Department of Philosophy, University of Milan, 20122 Milan, Italy.

Marianna Masiero (M)

Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.
Applied Research Division for Cognitive and Psychological Science, IEO European Institute of Oncology, IRCCS, 20141 Milan, Italy.

Ketti Mazzocco (K)

Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.
Applied Research Division for Cognitive and Psychological Science, IEO European Institute of Oncology, IRCCS, 20141 Milan, Italy.

Giulia Veronesi (G)

Faculty of Medicine and Surgery, Vita-Salute San Raffaele University, 20132 Milan, Italy.
Division of Thoracic Surgery, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.

Patrick Maisonneuve (P)

Division of Epidemiology and Biostatistics, IEO European Institute of Oncology, IRCCS, 20141 Milan, Italy.

Costantino Jemos (C)

Division of Pharmacy, IEO European Institute of Oncology, IRCCS, 20141 Milan, Italy.

Emanuela Omodeo Salè (EO)

Division of Pharmacy, IEO European Institute of Oncology, IRCCS, 20141 Milan, Italy.

Stefania Spina (S)

Division of Thoracic and General Surgery, Humanitas Research Hospital, 20089 Milan, Italy.

Raffaella Bertolotti (R)

Division of Thoracic Surgery, IEO European Institute of Oncology, IRCCS, 20141 Milan, Italy.

Derna Busacchio (D)

Applied Research Division for Cognitive and Psychological Science, IEO European Institute of Oncology, IRCCS, 20141 Milan, Italy.

Gabriella Pravettoni (G)

Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.
Applied Research Division for Cognitive and Psychological Science, IEO European Institute of Oncology, IRCCS, 20141 Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH